Amcor account plan
consumer healthcare packaging expertise
At a glance
Amcor makes flexible and rigid consumer packaging, with $23,506 million of fiscal 2026 sales, about 75,000 employees and 400 locations.
Amcor plc develops and produces primary consumer packaging and dispensing solutions across flexible and rigid materials for nutrition, health, beauty and wellness categories. Incorporated in Jersey with its primary executive office in Zurich, it is listed on the NYSE (AMCR) and ASX (AMC) and employs approximately 75,000 people across approximately 400 locations in more than 40 countries. Fiscal 2026 (year to June 30, 2026), the first full year after the Berry Global merger closed on April 30, 2025, brought net sales of $23,506 million (+57%), net income attributable to Amcor of $1,106 million and adjusted diluted EPS of $4.02. North America is 50% of sales. The fiscal year is moving to a December 31 year-end, and select corporate functions are to begin moving to a new U.S. headquarters in Miami from 2027.
Business units
Global Flexible Packaging Solutions
approximately 55% of fiscal 2026 net sales ($12,829 million)Polymer, aluminum and fiber-based flexible packaging (films, pouches, bags, foil, flexible trays and specialty folding cartons) for food and beverage, medical and pharmaceutical and personal care customers, from approximately 190 facilities in 33 countries with approximately 36,000 employees. Fiscal 2026 Adjusted EBIT rose 28% to $1,789 million (margin 13.9%). Led since 2026 by Division President Ryan D. Yost, previously of Avery Dennison.
Global Rigid Packaging Solutions
approximately 45% of fiscal 2026 net sales ($10,677 million)Rigid containers, preforms, closures, dispensing systems, trigger sprayers and pharma drug-delivery devices, mainly for beverage, food and personal care, from approximately 210 facilities in 33 countries with approximately 38,000 employees. Sales more than doubled with Berry and Adjusted EBIT rose 170% to $1,176 million (margin 11.0%). Led by Division President Jean-Marc Galvez, formerly of Berry.
Strategic priorities
- Deliver the Berry synergy plan
- Target of $650 million of synergies by June 30, 2028 ($530 million cost, $60 million financial, $60 million growth); fiscal 2026 delivered $285 million, about 10% ahead of plan, with the majority expected by end-2027.
- Grow the six focus categories
- Protein, liquids, foodservice, pet care, health care and beauty and wellness are more than 50% of core sales; focus-category volumes grew 3% in the quarter ended September 30, 2026.
- Emerging markets, global accounts and private label
- Emerging markets are about 20% of the portfolio, with China, India, Brazil and Mexico as priorities; a dedicated private-label team now targets large retailers and co-packers in North America and Europe.
- Portfolio pruning
- Businesses with about $2.5 billion of sales, including North American Beverage, were put under review in August 2025; six transactions have been agreed and five closed, while the North American beverage sale is taking longer.
- Deleveraging
- Leverage of 3.76x at September 30, 2026 is to fall to about 3.6x at December 31, 2026 and about 3x by end-2027, ahead of any bolt-on acquisitions.
- Sustainability
- Recycled-content targets for 2030 and net-zero by 2050, re-baselined after the Berry merger and validated by the Science Based Targets initiative in December 2025; fully recyclable products help customers minimize fees from new packaging regulations.
Latest results
In the quarter ended September 30, 2026 (the first quarter of a six-month transition period to a December year-end), net sales rose 7% to $6,129 million, of which about $435 million came from passing through higher raw-material costs, while divestitures cut about $112 million. Volumes rose about 1%, led by pet food, foodservice and beauty and wellness, and grew in all geographies. GAAP net income fell 8% to $242 million; Adjusted EBIT was $689 million and adjusted diluted EPS $0.95 (vs $0.97). Free cash outflow was $820 million on resin-related working capital, and net debt reached $14,011 million. The transition-period adjusted EPS outlook was cut to $1.70-$1.80 from $1.80-$1.90 on the timing of passing through higher energy and distribution costs; management expects double-digit adjusted EPS growth in 2027.
Investments and deals
- Berry Global merger
- Completed April 30, 2025 for $10.4 billion of purchase consideration plus approximately $5.2 billion of assumed Berry debt; integration spend has used $190 million of the $280 million budget.
- Divestments
- In fiscal 2026 Amcor sold four review businesses for $298 million of cash and its ePac investment for about $79 million; the CEO letter counts five non-core divestitures representing about $500 million of annual revenue.
- Capital spending
- Capex was $922 million in fiscal 2026 and runs at roughly 5% of sales; Amcor is adding capacity in China.
- Innovation
- About $170 million of R&D in fiscal 2026, approximately 1,500 R&D professionals and ten Innovation Centers; the Moda acquisition gives a significant share of new protein equipment installations.
- Refinancing
- €1.5 billion of euro notes issued in November 2025 and $1.5 billion of notes in March 2026, while Berry secured notes were redeemed early.
Challenges and risks
- Input-cost inflation from the Middle East conflict
- The conflict that began in February 2026 had an unprecedented impact on certain raw-material costs, and energy and distribution costs accelerated in September 2026, sized at $100-plus million gross.
- Working capital and leverage
- About $500 million of working capital was tied up by the conflict, to be recovered by end-2027; net debt stood at $14,011 million at September 30, 2026.
- Soft volumes in parts of the portfolio
- Excluding the merger, fiscal 2026 sales fell about 2% on lower volume; non-core volumes and North American unconverted films were weak.
- Integration and portfolio execution
- Delivering Berry synergies and completing the North American beverage sale are named execution risks.
- Regulation and customer pressure
- Packaging-waste rules (including EU packaging rules), customer consolidation and tariff volatility weigh on demand and prices.
What leadership says
“We delivered solid operating results this quarter, with broad-based organic volume growth of 1%, led by 3% volume growth in the focus categories.”
“We want to sell that business, find a better owner to it and then move on.”
“I think we're really just scratching the surface.”
“So much of this is diesel movement oriented.”
Where a supplier can help
- Freight and logistics cost
- Rising energy and distribution costs are a stated headwind, and Amcor is working on full-truckload use and freight rates, which opens room for logistics optimisation and freight providers.
- Procurement and integration synergies
- The $530 million cost-synergy target (procurement, supply chain, G&A) favours suppliers that help consolidate spend across the legacy Amcor and Berry footprint.
- Working-capital tools
- The goal to recover about $500 million of working capital, with structural targets on inventory days, DSO and payables, fits receivables, inventory and treasury solutions.
- Recyclable materials and regulatory compliance
- The sustainability priority and new packaging regulations create demand for recycled resin, recyclable material and compliance-reporting suppliers.
- Emerging-market capacity
- Capacity additions in China and the push for growth in India, Brazil and Mexico point to equipment and construction suppliers in those markets.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Amcor?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Annual Report FY26 (including Form 10-K for the fiscal year ended June 30, 2026)
- Amcor calls itself the global leader in primary consumer packaging and dispensing solutions for nutrition, health, beauty and wellness: approximately 75,000 employees, approximately 400 locations, more than 40 countries; Jersey-incorporated, primary executive office in Zurich, listed on the NYSE (AMCR) and ASX (AMC).
- Fiscal 2026 (year to June 30, 2026), the first full year after the Berry Global merger (closed April 30, 2025): net sales $23,506 million (+57%), net income attributable to Amcor $1,106 million (+116%), diluted EPS $2.38, Adjusted EBIT $2,813 million, adjusted diluted EPS $4.02 (+13%), adjusted EBITDA $3.7bn at a 15.6% margin. Excluding the merger, currency and raw-material pass-through, sales fell about 2% on lower volume.
- Two reportable segments: Global Flexible Packaging Solutions ($12,829 million, ~55% of sales, Adjusted EBIT margin 13.9%) and Global Rigid Packaging Solutions ($10,677 million, ~45%, margin 11.0%). North America is half of sales ($11.7bn); emerging markets about $5 billion.
- Berry integration: $285 million of synergies in fiscal 2026, 10% ahead of plan; the $650 million three-year target ($530 million cost, $60 million financial, $60 million growth) is due by June 30, 2028. New business wins reached about half of the $280 million revenue-synergy goal.
- Portfolio pruning: businesses with about $2.5 billion of sales, including North American Beverage, are under review; five non-core businesses with about $500 million of annual revenue were divested during the year.
- Balance sheet and returns: net debt $12.9 billion (June 30, 2026), $1.2 billion returned as dividends, annual dividend raised to $2.60; capex $922 million; operating cash flow $2,151 million. A 1-for-5 reverse split took effect January 14, 2026.
- Changes ahead: the fiscal year moves to a December 31 year-end (six-month transition period July-December 2026); select corporate functions are to begin moving to a new U.S. headquarters in Miami from 2027; new Flexibles division president Ryan Yost (ex-Avery Dennison) joined in 2026.
- Main risks: the Middle East conflict that began in February 2026 drove "unprecedented" input-cost inflation and supply disruption; soft consumer demand, tariffs, customer consolidation, integration execution, the portfolio review and leverage.
- Amcor Reports Solid Results for Quarter ended September 30, 2026 (Form 8-K Exhibit 99.1)
- Quarter ended September 30, 2026 (first quarter of the six-month transition period to a December year-end): net sales $6,129 million, up 7% (6% in constant currency), of which about $435 million (8%) came from passing through higher raw-material costs; divestitures cut sales by about $112 million.
- Volumes rose about 1% (about 1.5% excluding non-core and divested businesses), broad-based across nearly all end markets, led by pet food, foodservice and beauty and wellness, and up in all geographies, led by emerging markets.
- GAAP net income $242 million (down 8%), diluted EPS $0.52; adjusted EBITDA $883 million; Adjusted EBIT $689 million, flat in constant currency; adjusted diluted EPS $0.95 (vs $0.97).
- Berry synergies of about $50 million in Adjusted EBIT; the CEO says Amcor is on track for the three-year $650 million target.
- Flexibles: sales $3,359 million (+10%), Adjusted EBIT $414 million (+1%), margin 12.3% (13.6% excluding pass-through dilution). Rigid: sales $2,770 million (+3%), Adjusted EBIT $303 million (-3%), volumes about 4% higher excluding non-core and divestitures.
- Free cash outflow of $820 million on working-capital effects of resin price volatility linked to the Middle East conflict; net debt $14,011 million.
- Outlook for the transition period cut to adjusted EPS of $1.70-$1.80 (from $1.80-$1.90) because of the timing of passing through higher energy and distribution costs; leverage of about 3.6x expected at December 31, 2026. Quarterly dividend raised to 66.0 cents.
- Amcor (AMCR) Fiscal 2026 Fourth Quarter Earnings Call Transcript
- Fiscal 2026 fourth-quarter and full-year call (August 12, 2026), CEO Peter Konieczny and CFO Steve Scherger: Q4 adjusted EPS $1.23 (+23%) and fiscal 2026 adjusted EPS $4.02 (+13%), meeting the double-digit growth target set a year earlier.
- Volumes inflected to modest growth in Q4, about 200 basis points better sequentially, broad-based across segments, regions and focus categories; July continued in line with Q4.
- Synergies: $115 million in Q4, $285 million for the year, about 10% ahead of year-one expectations; $650 million three-year target confirmed. Growth-synergy wins of nearly $140 million, half of the $280 million three-year goal.
- Core portfolio: $21 billion of sales, EBIT margin about 12.7%; six focus categories (protein, liquids, foodservice, pet care, health care, beauty and wellness) are more than 50% of core sales.
- Free cash flow $1.3 billion, $200 million below outlook, because the Middle East conflict tied up about $500 million of working capital; management targets recovering more than $500 million over 12 months. Leverage 3.5x.
- Outlook: transition period (July-December 2026) adjusted EPS $1.80-$1.90; "line of sight" to double-digit adjusted EPS growth in calendar 2027, leverage about 3x by end-2027, capex about 5% of sales.
- Konieczny calls 2027 the first "clean year" after the Berry combination and expects outperformance versus the market; health care volumes fall on mix shift away from lower-margin medical toward pharma devices.
- Amcor (AMCR) Earnings Call Transcript, Quarter Ended September 30, 2026
- Call of November 4, 2026 on the quarter ended September 30, 2026, CEO Peter Konieczny and CFO Steve Scherger: volumes +1%, focus categories +3%, the fourth consecutive quarter of sequential improvement; adjusted EPS $0.95; synergies $60 million.
- Transition-period EPS outlook cut to $1.70-$1.80 because energy and distribution costs accelerated in September; Scherger sizes this inflation at "$100-plus million" gross, with price actions and contract clauses meant to catch up by end-December and no impact expected on 2027.
- Growth levers: six focus categories (pet food and foodservice strongest), emerging markets (China is "a bit more than $1 billion" business growing high single digits), global accounts, and a new dedicated private-label team for large retailers and co-packers in North America and Europe.
- Growth-synergy awards now $170 million of annual sales; Amcor expects to exceed the $280 million three-year target; majority of the $650 million synergy target by end-2027.
- Portfolio: six divestitures agreed, five closed; the sale of the North American beverage business is "taking a little longer" but remains the goal; future bolt-on targets could be in upstream films, protein and health care.
- Cash: $820 million free cash outflow in the quarter, about $500 million of Middle East working capital to be recovered by end-2027, leverage 3.76x heading to about 3.6x at year-end and about 3x by end-2027; capex about 5% of sales.
- 2027: double-digit adjusted EPS growth expected; Konieczny says Amcor moves "with market" now and is outperforming in more and more areas.
Questions about Amcor
What does Amcor do?
Amcor develops and produces flexible and rigid primary consumer packaging and dispensing solutions for nutrition, health, beauty and wellness categories, sold mainly through its own direct sales force.
What is Amcor's revenue?
Net sales were $23,506 million in fiscal 2026 (year to June 30, 2026), up 57% with the Berry Global merger. In the quarter ended September 30, 2026 sales were $6,129 million.
How many employees does Amcor have?
Approximately 75,000 people across approximately 400 locations in more than 40 countries.
Who leads Amcor?
Peter Konieczny is CEO, Stephen R. Scherger is CFO and Graeme Liebelt is Chairman.
What is Amcor's strategy?
Deliver the $650 million Berry synergy plan, grow six focus categories and emerging markets, sell non-core businesses and reduce leverage to about 3x by end-2027.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)